Insider Trading Activity Bio-Rad Laboratories, Inc. (NYSE:BIO) – EVP Sold 700 shares of Stock

Insider Trading Activity For Bio-Rad Laboratories, Inc. (NYSE:BIO)

Michael Crowley , EVP of Bio-Rad Laboratories, Inc. (NYSE:BIO) reportedly Sold 700 shares of the company’s stock at an average price of 215.91 for a total transaction amount of $151,137.00 SEC Form

Insider Trading History For Bio-Rad Laboratories, Inc. (NYSE:BIO)

On 11/9/2016 James R. Stark, VP, sold 1,299 with an average share price of $171.42 per share and the total transaction amounting to $222,674.58.View SEC Filing

On 3/7/2017 Michael Crowley, EVP, sold 300 with an average share price of $196.13 per share and the total transaction amounting to $58,839.00.View SEC Filing

On 8/11/2017 Michael Crowley, EVP, sold 700 with an average share price of $215.91 per share and the total transaction amounting to $151,137.00.View SEC Filing

Analyst Ratings For Bio-Rad Laboratories, Inc. (NYSE:BIO)
These are 4 Buy Ratings .
The current consensus rating for Bio-Rad Laboratories, Inc. (NYSE:BIO) is Buy (Score: 3.00) with a consensus target price of $225.00 , a potential (4.22% upside)

Analyst Ratings History For Bio-Rad Laboratories, Inc. (NYSE:BIO)

with a price target of $143.00 to $149.00
• On 10/12/2016 CL King Initiated Coverage of rating Buy with a price target of $180.00
• On 6/28/2017 Deutsche Bank AG Upgraded rating Hold to Buy with a price target of $220.00 to $195.00
• On 7/13/2017 Wells Fargo & Company Initiated Coverage of rating Outperform to Outperform with a price target of $250.00
• On 7/14/2017 Jefferies Group LLC Reiterated Rating Buy with a price target of $275.00

Recent Trading Activity for Bio-Rad Laboratories, Inc. (NYSE:BIO)
Shares of Bio-Rad Laboratories, Inc. closed the previous trading session at 215.89 up +0.89 0.41% with 232,899 shares trading hands.